MARKET

GRAL

GRAL

Grail Inc
NASDAQ
39.29
-4.59
-10.45%
After Hours: 39.80 +0.51 +1.31% 19:19 02/27 EST
OPEN
45.00
PREV CLOSE
43.87
HIGH
45.99
LOW
39.08
VOLUME
959.29K
TURNOVER
--
52 WEEK HIGH
63.99
52 WEEK LOW
12.33
MARKET CAP
1.33B
P/E (TTM)
-0.6183
1D
5D
1M
3M
1Y
5Y
1D
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 1d ago
Weekly Report: what happened at GRAL last week (0217-0221)?
Weekly Report · 3d ago
GRAIL Full Year 2024 Earnings: Beats Expectations
Simply Wall St · 5d ago
Grail Inc. Reports Strong Galleri Revenue Growth Amid Net Loss
TipRanks · 6d ago
Grail Inc trading resumes
TipRanks · 6d ago
GRAIL SHARES REVERSE COURSE FROM PREMARKET GAINS; LAST DOWN 9.6%
Reuters · 6d ago
GRAIL Inc. Reports Strong Growth and Strategic Advances
TipRanks · 02/21 04:36
Grail projects FDA submission completion for Galleri by H1 2026 with expanded scalability
Seeking Alpha · 02/21 03:09
More
About GRAL
More
GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. It is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.
Recently
Symbol
Price
%Change

Webull offers Grail Inc stock information, including NASDAQ: GRAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRAL stock methods without spending real money on the virtual paper trading platform.